Details: Randomized, double-blind, placebo-controlled trial involving 338 outpatients with MDD, conducted over an 8-week monotherapy period (250mg BID). Initial results from the OLIVE trial are ...
SOUTHLAKE, Texas, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Trinity Investors, a leading alternative asset management firm, proudly announces a significant milestone achieved by portfolio company Nuclein, LLC ...